NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Holdings, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2013.
Key fourth quarter metrics (all percentage changes compare 4Q 2013 to 4Q 2012 unless noted):
- Revenues totaled $8.836 billion, an increase of 4.8 percent
- Net income attributable to HCA Holdings, Inc. totaled $424 million, or $0.92 per diluted share
- Adjusted EBITDA was $1.714 billion, an increase of 6.7 percent
- Cash flows from operating activities totaled $1.226 billion, a decline of 2.9 percent
- Same facility equivalent admissions declined 1.0 percent, while same facility admissions declined 1.8 percent
- Same facility revenue per equivalent admission increased 4.8 percent
HCA President and Chief Executive Officer, R. Milton Johnson, said, "We are extremely pleased with the results for the quarter and the year. As we look to 2014, we will continue our focus on improving patient quality and experience, growth and efficiency. We believe we are well positioned for continued success in our markets.”
Revenues in the fourth quarter totaled $8.836 billion, compared to $8.434 billion in the fourth quarter of 2012. Fourth quarter revenue growth was driven primarily by higher revenue per equivalent admission as case mix, or acuity, increased 3.0 percent compared to the prior year. Same facility total surgical volume in the quarter increased 1.4 percent compared to the prior year.
Same facility equivalent admissions declined 1.0 percent while same facility admissions declined 1.8 percent in the fourth quarter of 2013 compared to the fourth quarter of 2012. Same facility emergency room visits declined 2.4 percent in the fourth quarter of 2013 compared to the prior year period. The decline in admissions in the fourth quarter was primarily due to a reduction in pulmonary and short-stay admissions from the prior year. Also, last year’s fourth quarter same facility volume was strong due, in large part, to the severity of the 2012 flu season, presenting difficult comparisons to the prior year volumes.
Revenue per equivalent admission increased 4.6 percent in the fourth quarter of 2013 (4.8 percent increase on a same facility basis), primarily reflecting increasing acuity and changes in payor mix. During the fourth quarter same facility inpatient surgeries increased 0.9 percent while same facility outpatient surgeries increased 1.6 percent compared to the prior year period.
The Company’s operating expense per equivalent admission, excluding electronic health record (EHR) and equity income, increased 3.5 percent from the prior year’s fourth quarter (4.1 percent increase including EHR and equity income). During the fourth quarter of 2013, salaries and benefits, supplies and other operating expenses totaled $7.172 billion, or 81.2 percent of revenues, compared to $6.918 billion, or 82.0 percent of revenues, in the fourth quarter of 2012.
Net income attributable to HCA Holdings, Inc. totaled $424 million, or $0.92 per diluted share, compared to $314 million, or $0.68 per diluted share, in the fourth quarter of 2012. Results for the fourth quarter of 2012 include pretax legal claim costs of $175 million, or $0.24 per diluted share, and pretax gains on sales of facilities of $11 million, or $0.01 per diluted share. Adjusted EBITDA for the fourth quarter of 2013 increased 6.7 percent to $1.714 billion compared to $1.606 billion in the prior year period. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Holdings, Inc. to Adjusted EBITDA is included in this release.
Twelve Months Ended December 31, 2013
Revenues for the year ended December 31, 2013 totaled $34.182 billion compared to $33.013 billion for 2012. Net income attributable to HCA Holdings, Inc. for 2013 was $1.556 billion, or $3.37 per diluted share, compared to $1.605 billion, or $3.49 per diluted share, for the year ended December 31, 2012. Results for the year ended December 31, 2013 include losses on sales of facilities of $10 million, or $0.02 per diluted share, and a loss on retirement of debt of $17 million, or $0.02 per diluted share. Results for the year ended December 31, 2012 include net favorable Medicare adjustments which increased revenues by $188 million, Adjusted EBITDA by $170 million and diluted earnings per share by $0.22. Results for 2012 also include legal claim costs of $175 million, or $0.24 per diluted share, and gains on sales of facilities of $15 million, or $0.02 per diluted share.
Balance Sheet and Cash Flow
As of December 31, 2013, HCA Holdings, Inc.’s balance sheet reflected cash and cash equivalents of $414 million, total debt of $28.376 billion, and total assets of $28.831 billion. During the fourth quarter of 2013, capital expenditures totaled $596 million, excluding acquisitions. During November, the Company paid $500 million to repurchase 10,656,436 shares of its common stock from certain of its sponsors. Net cash provided by operating activities in the fourth quarter of 2013 totaled $1.226 billion compared to $1.263 billion in the prior year’s fourth quarter.
As of December 31, 2013, HCA operated 165 hospitals and 115 freestanding surgery centers.
|
2014 Guidance |
|||
|
Today, HCA issued the following estimated guidance for 2014: |
|||
|
2014 Range |
|||
| Revenues | $35.50 - $36.50 billion | ||
| Adjusted EBITDA | $6.60 - $6.85 billion | ||
| Adjusted EPS (diluted) | $3.45 - $3.75 | ||
| Capital Expenditures | Approximately $2.2 billion | ||
This guidance assumes a benefit to Adjusted EBITDA from the Patient Protection and Affordable Care Act (Health Reform Law) in 2014 of approximately 1 to 2 percent of Adjusted EBITDA. The guidance also includes estimated electronic health record incentive income assumptions in a range of $110-$130 million and EHR expenses in a range of $110-$130 million. The Company’s guidance also includes an estimated increase in share-based compensation expense to approximately $168 million from $113 million in 2013. Guidance excludes the impact of items, if applicable, that are non-operational in nature including items such as, but not limited to, gains or losses on sales of facilities and businesses, gains or losses on early debt retirement and impairments of long-lived assets. This guidance is also subject to certain conditions including those as set forth below in the Company’s “Forward-Looking Statements”.
The Company’s 2014 annual stockholders’ meeting will be held in Nashville, Tennessee on April 23, 2014 at 2:00 p.m. local time for stockholders of record as of February 28, 2014.
Earnings Conference Call
HCA will host a conference call for investors at 9:00 a.m. Central Standard Time today. All interested investors are invited to access a live audio broadcast of the call via webcast. The broadcast also will be available on a replay basis beginning this afternoon. The webcast can be accessed at: https://event.webcasts.com/starthere.jsp?ei=1028374 or through the Company’s Investor Relations web page at www.hcahealthcare.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include statements that do not relate solely to historical facts. Forward-looking statements can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, (2) the effects related to the implementation of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the “Health Reform Law”), possible delays in or complications related to implementation of the Health Reform Law, the possible enactment of additional federal or state health care reforms and possible changes to the Health Reform Law and other federal, state or local laws or regulations affecting the health care industry, (3) the effects related to the continued implementation of the sequestration spending reductions required under the Budget Control Act of 2011 (the “BCA”) and the potential for future deficit reduction legislation that may alter BCA-mandated spending reductions, which include cuts to Medicare payments, or create additional spending reductions, (4) increases in the amount and risk of collectability of uninsured accounts and deductibles and copayment amounts for insured accounts, (5) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (6) possible changes in the Medicare, Medicaid and other state programs, including Medicaid upper payment limit programs or waiver programs, that may impact reimbursements to health care providers and insurers, (7) the highly competitive nature of the health care business, (8) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under managed care agreements, the ability to enter into and renew managed care provider agreements on acceptable terms and the impact of consumer driven health plans and physician utilization trends and practices, (9) the efforts of insurers, health care providers and others to contain health care costs, (10) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (11) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (12) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (13) changes in accounting practices, (14) changes in general economic conditions nationally and regionally in our markets, (15) future divestitures which may result in charges and possible impairments of long-lived assets, (16) changes in business strategy or development plans, (17) delays in receiving payments for services provided, (18) the outcome of pending and any future tax audits, appeals and litigation associated with our tax positions, (19) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (20) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments, and (21) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2012 and our other filings with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
All references to “Company” and “HCA” as used throughout this release refer to HCA Holdings, Inc. and its affiliates.
| HCA Holdings, Inc. | |||||||||||||
| Condensed Consolidated Comprehensive Income Statements | |||||||||||||
| Fourth Quarter | |||||||||||||
| (Dollars in millions, except per share amounts) | |||||||||||||
| 2013 | 2012 | ||||||||||||
|
Amount |
Ratio |
Amount |
Ratio |
||||||||||
| Revenues before provision for doubtful accounts | $9,962 | $9,538 | |||||||||||
| Provision for doubtful accounts | 1,126 | 1,104 | |||||||||||
| Revenues | 8,836 | 100.0 | % | 8,434 | 100.0 | % | |||||||
| Salaries and benefits | 3,965 | 44.9 | 3,865 | 45.8 | |||||||||
| Supplies | 1,564 | 17.7 | 1,501 | 17.8 | |||||||||
| Other operating expenses | 1,643 | 18.6 | 1,552 | 18.4 | |||||||||
| Electronic health record incentive income | (50) | (0.6) | (80) | (0.9) | |||||||||
| Equity in earnings of affiliates | - | - | (10) | (0.1) | |||||||||
| Depreciation and amortization | 461 | 5.2 | 425 | 4.9 | |||||||||
| Interest expense | 456 | 5.2 | 462 | 5.5 | |||||||||
| Gains on sales of facilities | (3) | - | (11) | (0.1) | |||||||||
| Legal claim costs | - | - | 175 | 2.1 | |||||||||
| 8,036 | 91.0 | 7,879 | 93.4 | ||||||||||
| Income before income taxes | 800 | 9.0 | 555 | 6.6 | |||||||||
| Provision for income taxes | 246 | 2.7 | 128 | 1.5 | |||||||||
| Net income | 554 | 6.3 | 427 | 5.1 | |||||||||
| Net income attributable to noncontrolling interests | 130 | 1.5 | 113 | 1.4 | |||||||||
| Net income attributable to HCA Holdings, Inc. | $424 | 4.8 | $314 | 3.7 | |||||||||
| Diluted earnings per share | $0.92 | $0.68 | |||||||||||
| Shares used in computing diluted earnings per share (000) | 458,535 | 461,131 | |||||||||||
| Comprehensive income attributable to HCA Holdings, Inc. | $541 | $297 | |||||||||||
| HCA Holdings, Inc. | |||||||||||||
| Condensed Consolidated Comprehensive Income Statements | |||||||||||||
| For the Years Ended December 31, 2013 and 2012 | |||||||||||||
| (Dollars in millions, except per share amounts) | |||||||||||||
| 2013 | 2012 | ||||||||||||
|
Amount |
Ratio |
Amount |
Ratio |
||||||||||
| Revenues before provision for doubtful accounts | $38,040 | $36,783 | |||||||||||
| Provision for doubtful accounts | 3,858 | 3,770 | |||||||||||
| Revenues | 34,182 | 100.0 | % | 33,013 | 100.0 | % | |||||||
| Salaries and benefits | 15,646 | 45.8 | 15,089 | 45.7 | |||||||||
| Supplies | 5,970 | 17.5 | 5,717 | 17.3 | |||||||||
| Other operating expenses | 6,237 | 18.2 | 6,048 | 18.3 | |||||||||
| Electronic health record incentive income | (216) | (0.6) | (336) | (1.0) | |||||||||
| Equity in earnings of affiliates | (29) | (0.1) | (36) | (0.1) | |||||||||
| Depreciation and amortization | 1,753 | 5.1 | 1,679 | 5.1 | |||||||||
| Interest expense | 1,848 | 5.4 | 1,798 | 5.4 | |||||||||
| Losses (gains) on sales of facilities | 10 | - | (15) | - | |||||||||
| Loss on retirement of debt | 17 | 0.1 | - | - | |||||||||
| Legal claim costs | - | - | 175 | 0.5 | |||||||||
| 31,236 | 91.4 | 30,119 | 91.2 | ||||||||||
| Income before income taxes | 2,946 | 8.6 | 2,894 | 8.8 | |||||||||
| Provision for income taxes | 950 | 2.8 | 888 | 2.7 | |||||||||
| Net income | 1,996 | 5.8 | 2,006 | 6.1 | |||||||||
| Net income attributable to noncontrolling interests | 440 | 1.2 | 401 | 1.2 | |||||||||
| Net income attributable to HCA Holdings, Inc. | $1,556 | 4.6 | $1,605 | 4.9 | |||||||||
| Diluted earnings per share | $3.37 | $3.49 | |||||||||||
| Shares used in computing diluted earnings per share (000) | 461,913 | 459,403 | |||||||||||
| Comprehensive income attributable to HCA Holdings, Inc. | $1,756 | $1,588 | |||||||||||
| HCA Holdings, Inc. | |||||||||||
| Supplemental Non-GAAP Disclosures | |||||||||||
| Operating Results Summary | |||||||||||
| (Dollars in millions, except per share amounts) | |||||||||||
| For the Years | |||||||||||
| Fourth Quarter | Ended December 31, | ||||||||||
|
2013 |
2012 |
2013 |
2012 |
||||||||
| Revenues | $8,836 | $8,434 | $34,182 | $33,013 | |||||||
| Net income attributable to HCA Holdings, Inc. | $424 | $314 | $1,556 | $1,605 | |||||||
| Losses (gains) on sales of facilities (net of tax) | (2) | (6) | 7 | (9) | |||||||
| Loss on retirement of debt (net of tax) | - | - | 11 | - | |||||||
| Legal claim costs (net of tax) | - | 110 | - | 110 | |||||||
|
Net income attributable to HCA Holdings, Inc., excluding losses (gains) on sales of facilities, loss on retirement of debt and legal claim costs (a) |
422 | 418 | 1,574 | 1,706 | |||||||
| Depreciation and amortization | 461 | 425 | 1,753 | 1,679 | |||||||
| Interest expense | 456 | 462 | 1,848 | 1,798 | |||||||
| Provision for income taxes | 245 | 188 | 959 | 947 | |||||||
| Net income attributable to noncontrolling interests | 130 | 113 | 440 | 401 | |||||||
| Adjusted EBITDA (a) | $1,714 | $1,606 | $6,574 | $6,531 | |||||||
| Diluted earnings per share: | |||||||||||
| Net income attributable to HCA Holdings, Inc. | $0.92 | $0.68 | $3.37 | $3.49 | |||||||
| Losses (gains) on sales of facilities | - | (0.01) | 0.02 | (0.02) | |||||||
| Loss on retirement of debt | - | - | 0.02 | - | |||||||
| Legal claim costs | - | 0.24 | - | 0.24 | |||||||
|
Net income attributable to HCA Holdings, Inc., excluding losses (gains) on sales of facilities, loss on retirement of debt and legal claim costs (a) |
$0.92 | $0.91 | $3.41 | $3.71 | |||||||
| Shares used in computing diluted earnings per share (000) | 458,535 | 461,131 | 461,913 | 459,403 | |||||||
|
(a) |
Net income attributable to HCA Holdings, Inc., excluding losses (gains) on sales of facilities, loss on retirement of debt and legal claim costs, and Adjusted EBITDA should not be considered as measures of financial performance under generally accepted accounting principles ("GAAP"). We believe net income attributable to HCA Holdings, Inc., excluding losses (gains) on sales of facilities, loss on retirement of debt and legal claim costs, and Adjusted EBITDA are important measures that supplement discussions and analysis of our results of operations. We believe it is useful to investors to provide disclosures of our results of operations on the same basis used by management. Management relies upon net income attributable to HCA Holdings, Inc., excluding losses (gains) on sales of facilities, loss on retirement of debt and legal claim costs, and Adjusted EBITDA as the primary measures to review and assess operating performance of its hospital facilities and their management teams. |
||||||||||
| Management and investors review both the overall performance (including: net income attributable to HCA Holdings, Inc., excluding losses (gains) on sales of facilities, loss on retirement of debt and legal claim costs, and GAAP net income attributable to HCA Holdings, Inc.) and operating performance (Adjusted EBITDA) of our health care facilities. Adjusted EBITDA and the Adjusted EBITDA margin (Adjusted EBITDA divided by revenues) are utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry. It is reasonable to expect that losses (gains) on sales of facilities and losses on retirement of debt will occur in future periods, but the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our health care facilities and complicate period comparisons of our results of operations and operations comparisons with other health care companies. | |||||||||||
| Net income attributable to HCA Holdings, Inc., excluding losses (gains) on sales of facilities, loss on retirement of debt and legal claim costs, and Adjusted EBITDA are not measures of financial performance under GAAP and should not be considered as alternatives to net income attributable to HCA Holdings, Inc. as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because net income attributable to HCA Holdings, Inc., excluding losses (gains) on sales of facilities, loss on retirement of debt and legal claim costs, and Adjusted EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, net income attributable to HCA Holdings, Inc., excluding losses (gains) on sales of facilities, loss on retirement of debt and legal claim costs, and Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies. | |||||||||||
| HCA Holdings, Inc. | |||||||||
| Condensed Consolidated Balance Sheets | |||||||||
| (Dollars in millions) | |||||||||
| December 31, | September 30, | December 31, | |||||||
| 2013 | 2013 | 2012 | |||||||
| ASSETS | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | $414 | $484 | $705 | ||||||
| Accounts receivable, net | 5,208 | 4,924 | 4,672 | ||||||
| Inventories | 1,179 | 1,135 | 1,086 | ||||||
| Deferred income taxes | 489 | 400 | 385 | ||||||
| Other | 747 | 828 | 915 | ||||||
| Total current assets | 8,037 | 7,771 | 7,763 | ||||||
| Property and equipment, at cost | 31,073 | 30,472 | 29,527 | ||||||
| Accumulated depreciation | (17,454) | (17,150) | (16,342) | ||||||
| 13,619 | 13,322 | 13,185 | |||||||
| Investments of insurance subsidiaries | 448 | 402 | 515 | ||||||
| Investments in and advances to affiliates | 121 | 125 | 104 | ||||||
| Goodwill and other intangible assets | 5,903 | 5,832 | 5,539 | ||||||
| Deferred loan costs | 237 | 250 | 290 | ||||||
| Other | 466 | 691 | 679 | ||||||
| $28,831 | $28,393 | $28,075 | |||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | $1,803 | $1,582 | $1,768 | ||||||
| Accrued salaries | 1,193 | 1,085 | 1,120 | ||||||
| Other accrued expenses | 1,913 | 1,764 | 1,849 | ||||||
| Long-term debt due within one year | 786 | 988 | 1,435 | ||||||
| Total current liabilities | 5,695 | 5,419 | 6,172 | ||||||
| Long-term debt | 27,590 | 27,389 | 27,495 | ||||||
| Professional liability risks | 949 | 959 | 973 | ||||||
| Income taxes and other liabilities | 1,525 | 1,670 | 1,776 | ||||||
| EQUITY (DEFICIT) | |||||||||
| Stockholders' deficit attributable to HCA Holdings, Inc. | (8,270) | (8,376) | (9,660) | ||||||
| Noncontrolling interests | 1,342 | 1,332 | 1,319 | ||||||
| Total deficit | (6,928) | (7,044) | (8,341) | ||||||
| $28,831 | $28,393 | $28,075 | |||||||
| HCA Holdings, Inc. | ||||||
| Condensed Consolidated Statements of Cash Flows | ||||||
| For the Years Ended December 31, 2013 and 2012 | ||||||
| (Dollars in millions) | ||||||
| 2013 | 2012 | |||||
| Cash flows from operating activities: | ||||||
| Net income | $1,996 | $2,006 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
| Changes in operating assets and liabilities | (4,272) | (3,663) | ||||
| Provision for doubtful accounts | 3,858 | 3,770 | ||||
| Depreciation and amortization | 1,753 | 1,679 | ||||
| Income taxes | 143 | 96 | ||||
| Losses (gains) on sales of facilities | 10 | (15) | ||||
| Loss on retirement of debt | 17 | - | ||||
| Legal claim costs | - | 175 | ||||
| Amortization of deferred loan costs | 55 | 62 | ||||
| Share-based compensation | 113 | 56 | ||||
| Other | 7 | 9 | ||||
| Net cash provided by operating activities | 3,680 | 4,175 | ||||
| Cash flows from investing activities: | ||||||
| Purchase of property and equipment | (1,943) | (1,862) | ||||
| Acquisition of hospitals and health care entities | (481) | (258) | ||||
| Disposition of hospitals and health care entities | 33 | 30 | ||||
| Change in investments | 36 | 16 | ||||
| Other | 9 | 11 | ||||
| Net cash used in investing activities | (2,346) | (2,063) | ||||
| Cash flows from financing activities: | ||||||
| Issuance of long-term debt | - | 4,850 | ||||
| Net change in revolving credit facilities | 970 | (685) | ||||
| Repayment of long-term debt | (1,662) | (2,441) | ||||
| Distributions to noncontrolling interests | (435) | (401) | ||||
| Payment of debt issuance costs | (5) | (62) | ||||
| Repurchase of common stock | (500) | - | ||||
| Distributions to stockholders | (16) | (3,148) | ||||
| Income tax benefits | 113 | 174 | ||||
| Other | (90) | (67) | ||||
| Net cash used in financing activities | (1,625) | (1,780) | ||||
| Change in cash and cash equivalents | (291) | 332 | ||||
| Cash and cash equivalents at beginning of period | 705 | 373 | ||||
| Cash and cash equivalents at end of period | $414 | $705 | ||||
| Interest payments | $1,832 | $1,723 | ||||
| Income tax payments, net | $694 | $618 | ||||
| HCA Holdings, Inc. | |||||||||||||||
| Operating Statistics | |||||||||||||||
| For the Years | |||||||||||||||
| Fourth Quarter | Ended December 31, | ||||||||||||||
|
2013 |
2012 |
2013 |
2012 |
||||||||||||
| Operations: | |||||||||||||||
| Number of Hospitals | 165 | 162 |
165 |
162 | |||||||||||
| Number of Freestanding Outpatient Surgery Centers | 115 | 112 | 115 | 112 | |||||||||||
| Licensed Beds at End of Period | 42,896 | 41,804 | 42,896 | 41,804 | |||||||||||
| Weighted Average Licensed Beds | 42,809 | 41,777 | 42,133 | 41,795 | |||||||||||
| Reported: | |||||||||||||||
| Admissions | 434,300 | 438,700 | 1,744,100 | 1,740,700 | |||||||||||
| % Change | -1.0% | 0.2% | |||||||||||||
| Equivalent Admissions | 716,200 | 715,000 | 2,844,700 | 2,832,100 | |||||||||||
| % Change | 0.2% | 0.4% | |||||||||||||
| Revenue per Equivalent Admission | $ | 12,337 | $ | 11,795 | $ | 12,016 | $ | 11,657 | |||||||
| % Change | 4.6% | 3.1% | |||||||||||||
| Inpatient Revenue per Admission | $ | 12,124 | $ | 11,470 | $ | 11,829 | $ | 11,475 | |||||||
| % Change | 5.7% | 3.1% | |||||||||||||
| Patient Days | 2,085,200 | 2,076,200 | 8,341,200 | 8,242,600 | |||||||||||
| % Change | 0.4% | 1.2% | |||||||||||||
| Equivalent Patient Days | 3,438,600 | 3,384,200 | 13,604,600 | 13,410,700 | |||||||||||
| % Change | 1.6% | 1.4% | |||||||||||||
| Inpatient Surgery Cases | 128,700 | 126,800 | 508,800 | 506,500 | |||||||||||
| % Change | 1.5% | 0.5% | |||||||||||||
| Outpatient Surgery Cases | 233,000 | 224,000 | 881,900 | 873,600 | |||||||||||
| % Change | 4.0% | 0.9% | |||||||||||||
| Emergency Room Visits | 1,754,300 | 1,785,400 | 6,968,100 | 6,912,000 | |||||||||||
| % Change | -1.7% | 0.8% | |||||||||||||
| Outpatient Revenues as a | |||||||||||||||
| Percentage of Patient Revenues | 38.8% | 38.7% | 37.9% | 38.1% | |||||||||||
| Average Length of Stay | 4.8 | 4.7 | 4.8 | 4.7 | |||||||||||
| Occupancy | 52.9% | 54.0% | 54.2% | 53.9% | |||||||||||
| Equivalent Occupancy | 87.1% | 88.0% | 88.4% | 87.7% | |||||||||||
| Same Facility: | |||||||||||||||
| Admissions | 429,200 | 437,000 | 1,735,500 | 1,734,300 | |||||||||||
| % Change | -1.8% | 0.1% | |||||||||||||
| Equivalent Admissions | 702,500 | 709,700 | 2,818,400 | 2,814,700 | |||||||||||
| % Change | -1.0% | 0.1% | |||||||||||||
| Revenue per Equivalent Admission | $ | 12,337 | $ | 11,770 | $ | 11,981 | $ | 11,637 | |||||||
| % Change | 4.8% | 3.0% | |||||||||||||
| Inpatient Revenue per Admission | $ | 12,208 | $ | 11,488 | $ | 11,859 | $ | 11,493 | |||||||
| % Change | 6.3% | 3.2% | |||||||||||||
| Inpatient Surgery Cases | 127,800 | 126,800 | 507,100 | 505,700 | |||||||||||
| % Change | 0.9% | 0.3% | |||||||||||||
| Outpatient Surgery Cases | 224,300 | 220,700 | 857,500 | 862,000 | |||||||||||
| % Change | 1.6% | -0.5% | |||||||||||||
| Emergency Room Visits | 1,726,700 | 1,770,000 | 6,908,900 | 6,860,400 | |||||||||||
| % Change | -2.4% | 0.7% | |||||||||||||
